Evidence map›Paper›PMID 42374596›Full record

ArticleTrials2026

A cluster randomized trial to evaluate the effects of a quality cluster-based intervention on the use of prostate-specific antigen test in general practice-a study protocol.

Pernille Hølmkjær, Christian Leick, Thomas Drivsholm, Volkert Siersma, Flemming Bro, Marius Brostrøm Kousgaard

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06748456 (Development and Evaluation of a Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06748456 narecruitingnot on this map

Development and Evaluation of a Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice: A Cluster Randomized Trial

TypeinterventionalSponsorUniversity of CopenhagenRan2024 to 2026Enrolled50ConditionsProstate Cancer, Evidence Based Medicine, Prostate Specific AntigenArmsPodcast, Cluster meeting, Hand-out material 1, Hand-out material 2
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pernille HølmkjærCentre of General Practice, University of Copenhagen, Copenhagen, Denmark.
Christian LeickCentre of General Practice, University of Copenhagen, Copenhagen, Denmark. christian.leick@sund.ku.dk.ORCID http://orcid.org/0009-0005-1304-1818
Thomas DrivsholmCentre of General Practice, University of Copenhagen, Copenhagen, Denmark.
Volkert SiersmaCentre of General Practice, University of Copenhagen, Copenhagen, Denmark.
Flemming BroResearch Unit for General Practice, Aarhus, Denmark.
Marius Brostrøm KousgaardCentre of General Practice, University of Copenhagen, Copenhagen, Denmark.

Funding

KiAP EMN-2022-01571
6 · The paper itself

Abstract

backgroundContinuous quality improvement is an important endeavor for keeping clinical practice up to date with research evidence and professional guidelines for the sake of patients and the rational use of system resources. Quality clusters are a framework for quality improvement in general practice, but the effects of working in quality clusters have not been evaluated in randomized trials. The use of prostate-specific antigen (PSA) tests in general practice represents a clinically relevant area for quality improvement due to recent guideline revisions, practice variation, and concerns about overuse. The objective of this study is to evaluate the effectiveness of a quality cluster-based intervention on the use of PSA tests in general practice.

methodsThe study is a cluster randomized controlled trial with an intervention group and a control group-receiving the intervention delayed-based in quality clusters in Denmark. We aim to include 50 quality clusters, each quality cluster having on average 13 general practice clinics. The intervention period is six months, and the total study period is 12 months. Randomization is 1:1 to intervention and control by a computer algorithm stratified by the five Danish health regions and cluster size. The intervention includes a cluster package about prostate-specific antigen used at a quality cluster meeting with data on use of prostate-specific antigen-tests, information on clinical guidelines, videos with clinicians, reflection questions, and hand-out materials to support implementation of changes to clinical practice. The control group proceeds with cluster work as usual and will receive the intervention delayed. Data for the primary and secondary outcomes will be obtained through registries and will be assessed at the end of the trial. DISCUSSION: We anticipate that the intervention will encourage general practitioners to reflect on their use of PSA testing and adjust their practice in accordance with the clinical guidelines if needed, and that this will result in an overall reduction in the use of the test.

trial registrationClinicaltrials.gov NCT06748456. Registered on 16.10.2024. https://clinicaltrials.gov/study/NCT06748456?id=NCT06748456&rank=1 . Retrospectively registered.

Indexed as

General PracticePractice Patterns, Physicians'Prostate-Specific AntigenProstatic NeoplasmsQuality ImprovementCluster AnalysisDenmarkHumansMalePredictive Value of TestsRandomized Controlled Trials as TopicTime FactorsProstate-Specific AntigenClinical guidelinesCluster randomized controlled trialComplex interventionEvidence-based medicineGeneral practiceProstate-specific antigen testQuality clusters

Identifiers

PMID42374596
PMCPMC13584573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.